Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.

Journal article

EMPA-KIDNEY Collaborative Group None. et al, (2024), N Engl J Med

Empagliflozin in Patients with Chronic Kidney Disease. Reply.

Journal article

Herrington WG. et al, (2023), N Engl J Med, 388, 2301 - 2302

Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomization study

Journal article

HERRINGTON W. et al, (2022), Clinical Journal of the American Society of Nephrology

Load More